Analyzing the role of the immune system and Immunotherapy in Triple Negative Breast Cancer (TNBC) Management (original) (raw)

Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy

Anastasia Constantinidou

Frontiers in Genetics

View PDFchevron_right

Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future Perspectives

Lamiae AMAADOUR

International Journal of Breast Cancer, 2020

View PDFchevron_right

Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?

Barbara Politynska

Cancer and Metastasis Reviews, 2022

View PDFchevron_right

Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects

Barbara Politynska

Drug Resistance Updates, 2017

View PDFchevron_right

Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice

Francesca Carlino

Cancers

View PDFchevron_right

Molecular Pathways: Involvement of Immune Pathways in the Therapeutic Response and Outcome in Breast Cancer

G. Curigliano

Clinical Cancer Research, 2013

View PDFchevron_right

Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects

aayushi shah

Medical Oncology

View PDFchevron_right

Biomarkers and potential targets for immune and cellular therapy in triple negative breast cancer

Lubov Vasina

Cellular therapy and transplantation, 2022

View PDFchevron_right

Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior

Cynthia Villarreal-Garza

Cancers

View PDFchevron_right

The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance

Małgorzata Bajor

Cancers

View PDFchevron_right

Where do the immune checkpoint inhibitors stand in the management of triple negative breast cancer?

Fadi Karak

Immunotherapy

View PDFchevron_right

Modulation of Immune System – Strategy in the Treatment of Breast Cancer

Laurentia Gales

In Vivo, 2021

View PDFchevron_right

Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women

David Casadevall

Breast Cancer Research and Treatment

View PDFchevron_right

Systemic immune mediators predict therapeutic response and tumor-infiltrating lymphocyte intensity in triple-negative breast cancer

Marina De Brot

2020

View PDFchevron_right

Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting

Henry Gomez

Clinical Medicine Insights: Oncology, 2016

View PDFchevron_right

Immunotherapy in Triple-Negative Breast Cancer: Present and Future

Tatiana Vidaurre

Current Breast Cancer Reports, 2019

View PDFchevron_right

Triple negative breast cancer: looking for the missing link between biology and treatments

Giuseppe Palma

Oncotarget, 2015

View PDFchevron_right

New Insights into the Role of the Immune Microenvironment in Breast Carcinoma

Luis De La Cruz-merino

Clinical and Developmental Immunology, 2013

View PDFchevron_right

What is the role of immunotherapy in breast cancer?

JACK CHAN

Chinese clinical oncology, 2018

View PDFchevron_right

The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy

Paola Defilippi

Frontiers in Oncology, 2021

View PDFchevron_right

Immunotherapy in Breast Cancer: When, How, and What Challenges?

Beatriz Henriques

Biomedicines

View PDFchevron_right

Immunotherapy in triple-negative breast cancer: A literature review and new advances

Tatiana Vidaurre

World journal of clinical oncology, 2022

View PDFchevron_right

The breast cancer immune microenvironment is modified by neoadjuvant chemotherapy

Susana Fiorentino

Scientific Reports, 2022

View PDFchevron_right

Immunotherapy: A Challenge of Breast Cancer Treatment

Marilina García Aranda

Cancers, 2019

View PDFchevron_right

Impact of tumor-infiltrating lymphocytes on pathological complete response after neoadjuvant chemotherapy in patients with early triple-negative breast cancer

Mustapha Oumouna

Medica Jadertina, 2021

View PDFchevron_right

Tumor infiltrating lymphocytes in triple negative breast cancer and correlations with prognosis

Patrizia Querzoli

Annals of Oncology, 2016

View PDFchevron_right

Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Can Boost Immune Disruption

Amal Ibrahim

Cancer Management and Research

View PDFchevron_right

Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profiles

Savithri Rangarajan

Oncotarget

View PDFchevron_right

The Immunology of Hormone Receptor Positive Breast Cancer

Yvonne Cui

Frontiers in Immunology, 2021

View PDFchevron_right

The role of immune checkpoint inhibitors in triplenegative breast cancer: recent developments and future perspectives

Journal of Cancer Metastasis and Treatment

Journal of Cancer Metastasis and Treatment, 2021

View PDFchevron_right

Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer

Semir Vranić, BJBMS Journal

Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer, 2019

View PDFchevron_right

If we build it they will come: targeting the immune response to breast cancer

Sofia Gameiro

NPJ breast cancer, 2019

View PDFchevron_right

Unveiling the Immune Microenvironment’s Role in Breast Cancer: A Glimpse into Promising Frontiers

Nektarios Alevizopoulos

International Journal of Molecular Sciences

View PDFchevron_right